Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

QUVIVIQ (1)

A to Z: Drugs in Highlight: Q is for QUVIVIQ®

News A to Z Feature 27/03/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is QUVIVIQ® (from Idorsia Pharamceuticals) is a medicine for treating adults with insomnia (difficulty falling asleep or staying asleep).

Read more
D Is For DURYSTA
News, A to Z Feature 12/12/2024

A to Z: Drugs in Highlight: D is for DURYSTA

Rebranding
Industry news, News 09/12/2024

Safeguarding Innovation: IP Considerations in Rebranding

CERDELGA
News, A to Z Feature 04/12/2024

A to Z: Drugs in Highlight: C is for CERDELGA

Secerna Website Images 2023 (63)
European, Industry news, News 03/12/2024

Extension of the European Patent Office’s Patent Prosecution Highway Programme

A To Z Drugs In Highlight B Is For BREO ELLIPTA
Industry news, News, A to Z Feature 28/11/2024

A to Z: Drugs in Highlight: B is for BREO ELLIPTA

Secerna Shares IP Law Insights With Durham University Students
Industry news, News, Careers 26/11/2024

Secerna Sparks Interest in IP Law at Durham University

EPO 2021
European, Industry news, News 19/11/2024

Unitary Patent: Legal provision to implement EU sanctions against Russia

A to Z: Drugs in Highlight: A is for AKEEGA®
News, A to Z Feature 15/11/2024

A to Z: Drugs in Highlight: A is for AKEEGA®

Sweden Aims to Protect Its Brand with Trademark Application
European, Industry news, News 13/11/2024

Sweden Aims to Protect Its Brand with Trademark Application

1 2 3 4 5 6 7 8 9 10